These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14571283)

  • 21. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of paracetamol 1-g oral solution bioavailability.
    Farre M; Roset PN; Abanades S; Menoyo E; Alvarez Y; Rovira M; Baena A
    Methods Find Exp Clin Pharmacol; 2008; 30(1):37-41. PubMed ID: 18389096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.
    Yue Y; Liu DJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):87-94. PubMed ID: 28816033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relative bioavailability of paracetamol in suppositories preparations in comparison to tablets].
    Blume H; Ali SL; Elze M; Krämer J; Wendt G; Scholz ME
    Arzneimittelforschung; 1994 Dec; 44(12):1333-8. PubMed ID: 7848353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
    Manitpisitkul P; Shalayda K; Russell L; Sanga P; Williams Y; Solanki B; Caruso J; Moyer JA
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):699-711. PubMed ID: 29125700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection.
    Szałek E; Karbownik A; Murawa D; Połom K; Urbaniak B; Grabowski T; Wolc A; Więckiewicz A; Grześkowiak E; Kokot ZJ; Murawa P; Burchardt P; Cieśla S
    Pharmacol Rep; 2014 Feb; 66(1):159-64. PubMed ID: 24905322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.
    Atkinson HC; Stanescu I; Frampton C; Salem II; Beasley CP; Robson R
    Clin Drug Investig; 2015 Oct; 35(10):625-32. PubMed ID: 26334726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative bioavailability of two novel coenzyme Q10 preparations in humans.
    Joshi SS; Sawant SV; Shedge A; Halpner AD
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):42-8. PubMed ID: 12564745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations.
    Kennedy JM; Tyers NM; Davey AK
    J Pharm Pharmacol; 2003 Oct; 55(10):1345-50. PubMed ID: 14607015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and pharmacokinetic profile of a newly-developed twice-a-day sustained-release paracetamol formulation.
    Liu DJ; Collaku A; Youngberg SP
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):172-81. PubMed ID: 25500485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3-Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers.
    Yue Y; Collaku A; Liu DJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):95-101. PubMed ID: 28816026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations.
    Smith S; Collaku A; Heaslip L; Yue Y; Starkey YY; Clarke G; Kronfeld N
    Drug Dev Ind Pharm; 2012 Mar; 38(3):372-9. PubMed ID: 21961887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paracetamol bioavailability study by means of salivary samples.
    Nejem RM; Issa MM; Shaat NT
    Pak J Biol Sci; 2007 May; 10(9):1553-5. PubMed ID: 19069976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.